COBO Technologies - Quality Control Genome Editing

📍 København N, Denmark🗓 Founded 2017👥 4 employees💰 Last funded Jul 2019
Biotechnology Research🌐 cobotechnologies.com
Website LinkedIn
COBO Technologies is a fast growing company based in Copenhagen, Denmark, that is specialised in products and services for QC of CRISPR modified cells and animals. The INDEL Profiling Platform - CIPP™, for detailed DNA mutation analysis, was launched in December 2017 and in January 2019 the company launched, PIPPR®, for extensive Protein/Proteome Expression profiling using label-free LC-MS. COBO Technologies support today customers globally in both the research and clinical fields.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in COBO Technologies - Quality Control Genome Editing?
COBO Technologies - Quality Control Genome Editing has 1 investor on record on gritt.io, including 1 early-stage backers.
When did COBO Technologies - Quality Control Genome Editing last raise funding?
The most recent investment in COBO Technologies - Quality Control Genome Editing recorded on gritt.io was in July 2019.
When was COBO Technologies - Quality Control Genome Editing founded?
COBO Technologies - Quality Control Genome Editing was founded in 2017.
What industry is COBO Technologies - Quality Control Genome Editing in?
COBO Technologies - Quality Control Genome Editing operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is COBO Technologies - Quality Control Genome Editing based?
COBO Technologies - Quality Control Genome Editing is headquartered in København N, Denmark.